Target intelligence / Profile preview

Bacterial nitroreductases and monoamine oxidase-like enzymes (NTR/MAO-like)

Target
NTR/MAO-like
Molecular classification
Enzyme, Oxidoreductase, Flavin-dependent enzyme, Flavoprotein
01

Overview

Bacterial nitroreductases (NTRs) and monoamine oxidase-like (MAO-like) enzymes are a group of flavin-dependent oxidoreductases that play critical roles in the metabolism of nitroaromatic and amine compounds. NTRs are primarily known for their ability to catalyze the reduction of nitro groups into highly reactive hydroxylamine or amino derivatives, a process exploited in the activation of several antimicrobial prodrugs such as nitrofurantoin and metronidazole. In addition to their role in treating bacterial and protozoal infections, NTRs are utilized in gene-directed enzyme prodrug therapy (GDEPT) to sensitize cancer cells to specific prodrugs. MAO-like enzymes in bacteria share structural similarities with human monoamine oxidases and are involved in the oxidative deamination of amines. Certain drugs, most notably furazolidone, interact with both enzyme types, acting as a prodrug substrate for NTRs while simultaneously inhibiting MAO activity. This dual interaction contributes to the drug's broad-spectrum antimicrobial efficacy but also necessitates caution regarding potential systemic side effects and drug-drug interactions.

Other names
NitroreductasesNTRsMonoamine oxidase-like proteinsFlavoenzymesType I nitroreductasesOxygen-insensitive nitroreductases
02

Mechanism of action

Reductive activation of nitro-containing prodrugs to cytotoxic intermediates (e.g., hydroxylamines and nitroso radicals) that damage DNA and proteins; Inhibition of monoamine oxidase activity.

03

Biological functions

Xenobiotic metabolismRedox homeostasisNitroreductionAmine oxidationCellular detoxification
04

Disease associations

InfectionCancerGastrointestinal diseaseUrinary tract infection
05

Safety considerations

GenotoxicityMutagenicityDrug-drug interactions (e.g., with tyramine or SSRIs due to MAO inhibition)Bacterial resistance (e.g., mutations in nfsA or nfsB genes)
06

Interacting drugs

Furazolidone

5 more in the full profile.

07

Biomarkers

nfsA gene expressionnfsB gene expressionNitroreductase enzymatic activityHypoxia levels (via NTR-sensitive probes)

Beyond the preview

Go deeper on Bacterial nitroreductases and monoamine oxidase-like enzymes (NTR/MAO-like).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial nitroreductases and monoamine oxidase-like enzymes (NTR/MAO-like).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call